Can You Get Mounjaro on the NHS? What’s Changing in 2025

Can You Get Mounjaro on the NHS? What’s Changing in 2025

Can You Get Mounjaro on the NHS? What’s Changing in 2025 

 

This past year, one question has exploded across the UK: Can you actually get Mounjaro on the NHS? 

 

Given the massive popularity of weight-loss injections like Wegovyit's no shock that folks are chasing real medical solutions that actually work — instead of fad diets or "miracle" supplements. 

 

2025 promises to be a significant year for obesity treatment on the NHS, and Mounjaro (tirzepatide) is finally entering the conversation. But who can get it, when it’ll roll out, and what it actually means for everyone else — that’s where things get interesting. 

 

The Key Points 

 

  • Mounjaro is now approved for NHS use to support weight loss in adults with obesity. 
  • Access will start through specialist clinics, rolling out in phases during 2025. 
  • By June 2025, some high-risk patients may get Mounjaro via GPs. 
  • The wider rollout will take time, and not everyone will qualify right away. 
  • Private, medically supervised access is available now for those meeting clinical criteria. 
  • Always choose a trusted, regulated provider to ensure safety and effective results. 

 

What is Mounjaro? 

 

Mounjaro (tirzepatide) is an injectable drug that works by focusing on two hormones — GLP-1 and GIP — that help control blood sugar, hunger, and energy use. 

 

Originally conceived as a treatment for type 2 diabetes, Mounjaro soon found itself in the spotlight due to its extraordinary effect on weight loss, with some studies showing a remarkable average loss of around 20% or more in patients taking part in clinical trials. 

 

It is being prescribed around the world for obesity and metabolic diseases, providing medicine with a scientifically backed alternative treatment. 

 

When Was Mounjaro Made Available on the NHS? 

 

Mounjaro (tirzepatide) received its final authorization for NHS use in late 2024, following guidance from NICE (the National Institute for Health and Care Excellence). But approval does not necessarily mean it will be immediately available to the public — more like a go-ahead for the NHS to begin introducing it over a period of time. 

 

The first wave started in 2025, early that year, focusing on specialist weight-management services and hospital-led clinics. These are the types of centers that already prescribe Wegovy and other GLP-1-based weight-loss drugs. 

 

The reason for the limited launch is mostly about training and infrastructure. Mounjaro is a strong treatment, and patients should be careful, especially during the initial months of medication. Training healthcare workers in: 

 

  • Start patients on the correct dosage 
  • Manage potential side effects 
  • Track progress safely over time 

 

The NHS plans for availability by mid-2025 in a few GP practices, which would make it easier to access the drug locally for more patients, especially those with obesity-related health problems. 

 

Who Is Eligible to Get Mounjaro on the NHS Right Now? 

 

Eligibility for Mounjaro on the NHS depends on specific health criteria. According to NICE, you may qualify if: 

 

  • You have a BMI of 35 or higher, and 
  • You have at least one weight-related health condition (like type 2 diabetes, hypertension, or sleep apnea). 

 

In some cases, adults with a BMI between 30 and 34.9 may also qualify if their condition significantly affects their health or quality of life. 

 

For now, prescriptions are only handled by specialist clinics with medical oversight and weight-management programs. 

 

What’s Changing in June 2025? 

 

June 2025 is when they start to open up. The NHS intends to widen access beyond specialist clinics, with some high-risk patients able to receive Mounjaro via GP practices. 

 

That extension is that if you suffer from obesity and all the related conditions (diabetes, cardiovascular risk), your pharmacist may now be able to prescribe Mounjaro without having to refer you to a hospital-based service. 

 

That said, it’s still going to be a gradual rollout — availability will depend on region, supply, and NHS capacity. 

 

What If You Don’t Fit the Criteria Right Now? 

 

So even if you don’t meet NHS criteria now, that doesn’t necessarily mean Mounjaro is totally off-limits. 

 

Mounjaro is already available through private clinics and regulated online providers to eligible adults who fit the medical criteria. You’ll still need a consultation to make sure you are a safe candidate, but it’s a far quicker road than hoping the NHS will approve. 

 

You should just ensure any provider you consider is licensed and clinically reviewed — stay away from shady websites selling unregulated versions. 

 

Why Isn’t Mounjaro Fully Accessible on the NHS? 

 

Perhaps it may seem unfair that a proven treatment (for weight loss) isn’t immediately available to anyone, but for good reasons, things are not so simple. 

 

1. Limited supply 

 

Now the world can’t get enough of Mounjaro after global demand soared. The manufacturer, Eli Lilly, is still ramping up production, so the NHS has to reserve doses for those who need it the most — people with severe obesity or related health problems like type 2 diabetes. 

 

2. Budget and sustainability 

 

Mounjaro is an expensive medication. The NHS has a limited budget, so it cannot be simply rolled out to millions of people overnight. NICE is trying to make sure that money is spent wisely and that it goes only to those who fulfill strict medical criteria under the NHS plan. 

 

3. Clinical monitoring 

 

Injectable weight loss drugs like Mounjaro aren’t “take and goprescriptions. They require pharmacist monitoring, periodic check-ins, and sometimes dose tweaking. The NHS wants to avoid overwhelming GP surgeries before proper systems are in place. 

 

Will Mounjaro Have a 2-Year Prescription Limit? 

 

Yes — at least for now. 

 

NICE has recommended a maximum of two-year limit on Mounjaro’s use through the NHS, which is similar to Wegovy. The approach is to avoid long-term dependence, where the results will be re-evaluated over time. Doctors will review your response in two years and determine whether you require further treatment based on medical need. 

 

It’s important to keep in mind that private treatment plans may provide longer-term support based on your health goals and results. 

 

Can You Get Mounjaro Privately? 

 

 

Yes, and for a lot of people, private access is the only way to begin treatment before the full NHS rollout. 

 

Registered online pharmacies and weight management clinics in the UK are currently offering Mounjaro to adults who fit the clinical criteria. You’ll still have to undergo a consultation and medical examination, since Mounjaro is a prescription medicine.

 

Here’s how private access usually works: 

 

  1. Complete a consultation: Online or in-person, with a licensed prescriber. 
  2. Medical review: A clinician checks your BMI, health history, and medication suitability. 
  3. Prescription & supply: If approved, your prescription is filled through a regulated UK pharmacy. 
  4. Follow-up support: Many providers offer progress tracking and dose adjustments. 

 

Access to a private one means you won’t have to wait months for an NHS referral — however, it’s important to pick a credible, regulated source. 

 

Unlicensed sites may not only counterfeit these products, but also offer versions that are fake or are otherwise dangerous. 

 

There are some verified providers like Cured Pharmacy that operate a safe and convenient process where every prescription is clinically reviewed by certified pharmacists before being dispatched.

 

Private treatment can also be more accommodating — providing longer-term, tailored support and easier contact. 

 

What Mounjaro Means for the Future of Weight-Loss Care 

 

The arrival of Mounjaro signals a turning point in the way the UK views obesity — not as a moral issue, but as a manageable medical condition. 

 

With further research and integration into the NHS, drugs such as Mounjaro could make effective, science-proven weight management available to millions. In the long run, that would result in fewer obesity related diseases and a healthier overall public. 

 

Mounjaro is paving the way for a future in which safe, clinically-based support replaces guesswork and fad dieting. 

 

What to Do Now 

 

 

If you believe you might be eligible for Mounjaro or another weight-loss treatment, the next step is to consult a health care professional. They can advise on eligibility, options, and whether to go NHS or private. 

 

Even if you’re not eligible yet, you can: 

  • Start improving your lifestyle habits. 
  • Track your health data (like BMI and blood sugar). 
  • Stay updated on the NHS rollout through official channels. 

 

And if you want the medication much faster, consider private, regulated care with full medical review — so you get both results and safety. 

Back to blog